• Ertugliflozin (PF-04971729): Translational Strategy

  2026-09-15

  A thought-leadership guide to using Ertugliflozin (PF-04971729) in diabetes mellitus research, renal glucose transport studies, weight-loss investigations, and exploratory intestinal inflammation models.

• JHU-083: A Compartment-Aware Assay Strategy

  2026-09-15

  JHU-083 is a 6-diazo-5-oxo-L-norleucine precursor for dissecting glutaminase-dependent glutamate biology. This article develops an assay framework that separates cell-selective glutamate effects from downstream oxidative-stress signals, using recent GSTA1 findings to sharpen experimental interpretation.

• C. difficile Mucus Responses in a Human Intestinal Model

  2026-09-14

  The reference study introduces a primary human intestinal epithelial cell model that produces physiologic mucus and enables direct analysis of Clostridioides difficile behavior without a resident microbiota. Integrated growth, transcriptomic, biophysical, and metabolic analyses show that mucus is not only a barrier but also a niche that can promote pathogen growth, biofilm formation, and flexible metabolic adaptation.

• Steroid Lysis of Protoplasts: Spermine Protection

  2026-09-14

  Smith and Shay used osmotically fragile Sarcina lutea protoplasts to distinguish direct membrane injury from indirect effects of synthetic antimicrobial steroids. Their central finding was that spermine tetrahydrochloride strongly protected protoplasts from steroid-induced lysis, supporting a membrane-centered mechanism and illustrating how protoplast assays can dissect antimicrobial action.

• Biotin (Vitamin B7): Mechanism & Workflows

  2026-09-13

  Biotin, also called Vitamin B7 or Vitamin H, is a water-soluble cofactor for five human carboxylases and a high-affinity ligand for avidin and streptavidin. This article separates its metabolic functions from its use in protein biotinylation, defines practical solvent and storage boundaries, and explains why the cited shrimp STING study does not establish a direct role for biotin.

• Asunaprevir (BMS-650032) HCV Research Workflow

  2026-09-12

  Build more reliable HCV protease studies with Asunaprevir (BMS-650032), combining genotype-aware dose response, replication readouts, and orthogonal viability controls. The workflow also adapts a high-throughput assay principle from chromatin biology without confusing mechanistic evidence across disease areas.

• Bobcat339 for TET-Driven DNA Methylation

  2026-09-11

  Bobcat339 offers a practical chemical perturbation strategy for connecting TET1/TET2 activity with DNA methylation, enhancer state, and osteogenic phenotypes. This workflow translates the UHRF1–TGM2 findings in senile osteoporosis into dose-response, molecular, and multi-omics experiments while emphasizing controls and assay-specific optimization.

• CLK2 Drives Platinum Resistance in Ovarian Cancer

  2026-09-11

  The reference study identifies Cdc2-like kinase 2 (CLK2) as a mediator of platinum resistance in ovarian cancer and links this phenotype to phosphorylation of BRCA1 at Ser1423 and enhanced DNA damage repair. Its combination of patient-tissue analysis, functional assays, mechanistic studies, and xenograft validation positions CLK2 as a preclinical target while also clarifying why broad Clk inhibitors require careful interpretation.

• Small-Molecule Pancreatic Ductal Organoids

  2026-09-10

  Liao and colleagues report a small-molecule culture strategy that improves the initiation, ductal enrichment, and long-term expansion of pancreatic ductal organoids. The resulting exocrine-focused cultures retain ductal and acinar components, offering a practical platform for studying pancreatic biology, cellular plasticity, and disease-relevant drug responses.

• EdU Imaging Kits (488) for HCC Proliferation

  2026-09-10

  EdU Imaging Kits (488) convert S-phase DNA synthesis into a sensitive fluorescence readout for hepatocellular carcinoma research, with imaging and flow cytometry compatibility. This workflow supports HAUS1 perturbation studies while preserving morphology and antigen-binding sites better than harsh BrdU denaturation workflows.

• Azathramycin A: A Translational Lens on TB Ribosomes

  2026-09-09

  Azathramycin A offers translational researchers a defined macrolide framework for studying ribosomal target engagement, protein synthesis inhibition, degradation chemistry, resistance, and the boundaries between antibacterial discovery and safety assessment.

• L-Phenylephrine: α1A Assay Workflows

  2026-09-09

  L-Phenylephrine is an adrenergic α1A receptor agonist for dissecting receptor-driven signaling in cardiomyocytes, neural progenitors, vascular models, and baroreflex experiments. This guide translates sex-aware hypertension findings into practical workflows, controls, and troubleshooting strategies for reproducible research.

• EZ Cap™ Firefly Luciferase mRNA: Translational Signal

  2026-09-08

  A thought-leadership framework for using Cap1 firefly luciferase mRNA as a systems-level reporter of delivery, translation, stability, and gene regulation—while translating new insights on N4-acetylcytidine into disciplined experimental design.

• Native PAGE for Translational CF Research

  2026-09-08

  A translational framework for combining iPSC-derived airway function with native protein analysis. The article explains how native protein gel electrophoresis can preserve biochemical context, clarify genotype-to-phenotype mechanisms, and strengthen decision-making around CFTR variant research.

• TRIM21, ERK1/2, and Drug Resistance in Pituitary Adenomas

  2026-09-07

  The reference study identifies TRIM21 as a context-dependent regulator of ERK1/2 signaling, pituitary adenoma proliferation, and resistance to dopamine agonists. Its combination of CRISPR screening, biochemical validation, and drug screening positions TRIM21 as a preclinical therapeutic target and identifies Quisinostat as a candidate for reducing TRIM21-associated tumor phenotypes.

7946 records 1/530 page Next 12345 下5页 Last page